Drugs

Resources for You

Current Drug Shortages A - D

The majority of information in this section is provided to FDA by manufacturers. Communication between FDA and the public is an essential component of preventing and mitigating drug shortages. To ensure that the information in this section is current, FDA appreciates all information and updates about shortages provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers. To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

**Listed by Generic name or Active Ingredient**

[A – D] E F G H I J K L M N O P Q R S T U V W X Y Z

Acetylcysteine Inhalation Solution

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	100 mg/mL; 30 mL vial (NDC 0409-3307-03)	Next delivery early June Estimated recovery: 3Q 2013	Please check with your wholesaler for available inventory.	Demand increase for the drug.	Revised 6/14/2013
Hospira Inc. Customer Service: 1-877-946-7747	200 mg/mL; 30 mL vial (NDC 0409-3308-03)	Next delivery early June 2013. Estimated recovery: 3Q 2013	Please check with your wholesaler for available inventory.	Demand increase for the drug.	Revised 6/14/2013
Roxane Laboratories 1-614-276-4000	100 mg/mL, 10 mL(NDC 00054-3027-02)	Unavailable	Roxane Laboratories has all acetylcysteine inhalation solution presentations on backorder and the company cannot provide an anticipate release date. Shortage per Manufacturer: Manufacturing Delay	Other	Revised 5/23/2013
	100 mg/mL, 30 mL (NDC 00054-3025-02)
	200 mg/mL, 10 mL (NDC 00054-3028-02)
	200 mg/mL, 30 mL (NDC 00054-3026-02)
American Regent/Luitpold 631-924-4000	100 mg/mL, 4 mL (NDC 00517-7504-25)	Unavailable	American Regent is currently not releasing Acetylcysteine inhalation solution.	Other	Reverified 6/18/2013
	100 mg/mL, 10 mL (NDC 00517-7510-03)
	200 mg/mL, 4 mL (NDC 00517-7604-25)
	200 mg/mL, 10 mL (NDC 00517-7610-03)
	200 mg/mL, 30 mL (NDC 00517-7630-03)

Acyclovir Sodium Injection (Initial Posting Date) - 11/13/2012

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP Customer Service 1-888-386-1300	500mg, 10mL (NDC # 63323-325-10)	Next delivery expected June 2013. Check wholesaler inventory.	All presentations currently on allocation with manufacturer. Shortage per manufacturer: Manufacturing delay	Demand increase for the drug	Revised 6/5/2013
	500mg, 10mL (NDC # 63323-325-10)			Demand increase for the drug
	1g, 20mL (NDC # 63323-325-20)
	1g, 20mL (NDC # 63323-325-20)

Alfentanil hydrochloride (Alfenta) (Initial Posting Date) - 1/23/2012

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Akorn Pharmaceuticals 1-800-932-5676	0.5 mg/ml; 2ml ampule (NDC 17478-0067-02)	Readily available	N/A	N/A	Reverified 4/3/2013
Akorn Pharmaceuticals 1-800-932-5676	0.5 mg/ml; 5ml ampule (NDC 17478-0067-05)	Readily available	N/A	N/A	Reverified 4/3/2013
Hospira, Inc. Customer Service: 1-877-946-7747	500 mcg/mL; 2 mL amp (NDC 0409-2266-02)	Available	Please check your wholesaler for all available inventory.	Available	Reverified 6/14/2013
Hospira, Inc. Customer Service: 1-877-946-7747	500 mcg/mL; 5 mL amp (NDC 0409-2266-05)	Available	Please check your wholesaler for all available inventory.	Available	Reverified 6/14/2013

Alteplase (Cathflo Activase) (Initial Posting Date – 2/27/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Genentech Customer Service: 1-800-551-2231 Medical Communications: 1-800-821-8590	Alteplase (Cathflo Activase), 2 mg vial (NDC 50242-0041-64)	Potential limited availability of Cathflo Activase 2mg vial is projected to continue into Q2 2013	Shortage per Manufacturer: Manufacturing Issues Contact your authorized Genentech distributor regarding product availability Some vials of Cathflo Activase have been found to contain rubber stopper particulates after reconstitution. Studies have indicated that filtration through a 5 micron filter needle is sufficient to remove these particles. Cathflo Activase vials should be carefully inspected after reconstitution for foreign matter or discoloration. Do not administer Cathflo Activase if particulate matter is discovered. There is a potential risk that particulate matter may cause embolic events if introduced into the bloodstream. Please see the Dear Pharmacist Letter (PDF - 352KB) for additional information.	Other	Revised 3/25/2013
	Alteplase (Activase), 50 mg vial (NDC 50242-044-13)	Available
	Alteplase (Activase) 100 mg vial (50242-085-27)	Available

Amikacin Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Teva Pharmaceuticals 1-800-545-8800	250 mg/mL 4 mL vials (NDC 00703-9040-03)	Teva has 4mL vials available on allocation.	Teva expects additional supply in April, and will be shipping to wholesalers. Product is currently available for dropship.	Demand increase for the drug.	Reverified 5/29/2013
Bedford Customer Service 1-800-562-4797	250 mg/mL, 2 mL vials (NDC 55390-0226-02)	Unavailable	Bedford Laboratories has 500mg/2ml and 1gm/4ml available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: Manufacturing delays	Discontinuation of the manufacture of the drug.	Revised- 4/10/2012
Bedford Customer Service 1-800-562-4797	250 mg/mL, 4 mL vials (NDC 55390-0226-04)	Unavailable		Discontinuation of the manufacture of the drug.	Revised- 4/10/2012

Amino Acids (Aminosyn II 10%, Aminosyn-HBC 7%, Trophamine, FreAmine III, FreAmine HBC, NephrAmine, HepatAmine, Travasol, Clinimix, Clinimix E, Pretasol, Prosol, Hepatasol) (Initial Posting Date) - 2/14/2012

For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition: Information to Use in the Event of an Intravenous Amino Acid Storage, 2013

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira, Inc. Customer Service: 1-877-946-7747	Aminosyn II 10%, Sulfite-free; 1 L bag (NDC 0409-4164-05)	Available	Please check with your wholesaler for available inventory. Shortage per manufacturer: Manufacturing delay	Other, Available.	Reverified 6/14/2013
	Aminosyn 10%, Sulfite-free; 500 mL bag (NDC 0409-4191-03)	Available
	Aminosyn 8.5%, Sulfite-free; 500 mL bag (NDC 0409-4187-03)	Available
	Aminosyn 8.5%, Sulfite-free; 500 mL bag (NDC 0409-4187-03)	Available
	Aminosyn II 15%, Sulfite-free; 2 L bag (NDC 0409-7171-17)	Available
	Aminosyn II 10%, Sulfite-free; 2 L bag (NDC 0409-7172-17)	Available
	Aminosyn 10%, Sulfite-free, 1 L (NDC 0409-4191-05)	Available
	Aminosyn II 10%, 500 mL, Sulfite-free (NDC 0409-4164-03)	Available
	Aminosyn HBC 7%, 500 mL, Sulfite-free (NDC 0409-4168-03)	Available
	Aminosyn 3.5%, sulfite-free, 1 L (NDC 0409-4196-05)	Available
	Aminosyn II 8.5%, sulfite-free, 500 mL (NDC 0409-4162-03)	Available
	Aminosyn II 8.5% with electrolytes, sulfite-free, 500 mL (NDC 0409-4171-03)	Available
		Available
	Aminosyn-PF 7%, sulfite-free, 500 mL (NDC 0409-4178-03)	Available
	Aminosyn-PF 10%, 1000 mL, sulfite-free (NDC 0409-4179-05)	Available
	Aminosyn RF 5.2%, 500 mL, sulfite-free (NDC 0409-4166-03)	Available
	Aminosyn II 10%; 2 L bag (NDC 0409-7121-07)	Product being replaced by (NDC 0409-7172-17)
B. Braun Medical Inc. Customer Service: 1-800-227-2862	TrophAmine 6%, 500 mL (NDC 00264-9361-55)	All presentations available			Revised 10/17/2012
	TrophAmine 10%, 500 mL (NDC 00264-9361-55)
	FreAmine III 10%, 1000 mL (NDC 00264-9010-55)
	Specialty Amino Acid Solutions FreAmine HBC 6.9%, 750 mL (NDC 00264-9350-55)
	NephrAmine 5.4%, 250 mL (NDC 00264-1909-55)
	HepatAmine 8%, 500 mL (NDC 00264-9371-55)
	15% Amino Acids Injection 1,000 mL (NDC 0264-3200-55)
Baxter Customer Service: 1-800-262-3784	Travasol 10%, 500 mL (NDC 00338-0644-03)	Baxter is currently experiencing a backorder situation on presentations of Prosol and Clinimix E due to unforeseen demand. Climinix is a viable source of Amino Acids for most patients requiring parenteral nutrition.		Demand increase for the drug	Revised 5/7/2013
	Travasol 10%, 1000 mL (NDC 00338-0644-04)
	Travasol 10%, 2000 mL (NDC 00338-0644-06)
	Prosol 20%, 2000 mL, sulfite-free (NDC 00338-0499-06)
	Clinisol 15%, 500 mL, sulfite-free (NDC 00338-0502-03)
	Clinisol 15%, 2000 mL, sulfite-free (NDC 00338-0502-06)
	Premasol 6%, 500 mL, sulfite-free (NDC 00338-1131-03)
	Premasol 10%, 500 mL, sulfite-free (NDC 00338-1130-03)
	Premasol 10%, 1000 mL, sulfite-free (NDC 00338-1130-04)
	Premasol 10%, 2000 mL, sulfite-free (NDC 00338-1130-06)
	Hepatosol 8%, 500 mL (NDC 00338-0504-03)
	CLINIMIX sulfite-free (2.75%, 4.25%, 5.0% Amino Acid in Dextrose) Injections in 1000 mL and 2000 mL Containers
	CLINIMIX E sulfite-free (2.75%, 4.25%, 5.0% Amino Acid with Electrolytes in Dextrose with Calcium) Injections in 1000 mL and 2000 mL Containers

Aminocaproic Acid Injection (Initial Posting Date 3/8/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	250 mg/mL; 20 mL vial (NDC 0409-4346-73)	Next delivery early June Estimated recovery: 4Q 2013	Shortage per Manufacturer: Capacity constraints.	Other	Revised 6/14/2013

Aminophylline (Initial Posting Date 12/10/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira, Inc. Customer Service: 1-877-946-7747	250mg/20mL (NDC 0409-5921-01)	Next delivery early June Estimated recovery: 3Q 2013	Shortage per Manufacturer: Manufacturing delay	Other	Revised 6/14/2013
500mg/20mL (NDC 0409-5922-01)	Available	Available

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Hospira, Inc. Customer Service:
1-877-946-7747

250mg/20mL

(NDC 0409-5921-01)

Next delivery early June

Estimated recovery: 3Q 2013

Shortage per Manufacturer: Manufacturing delay

Other

Revised
6/14/2013

500mg/20mL

(NDC 0409-5922-01)

Available

Ammonium Chloride Injection (Initial Posting Date 3/8/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira, Inc. Customer Service: 1-877-946-7747	5 mEq/mL; 20 mL vial (NDC 0409-6043-01)	Next delivery 3Q 2013 Estimated recovery: 3Q 2013	Please check with your wholesaler for available inventory. Shortage per Manufacturer: Manufacturing delay	Other	Reverified 6/14/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Hospira, Inc. Customer Service:
1-877-946-7747

5 mEq/mL; 20 mL vial

(NDC 0409-6043-01)

Next delivery 3Q 2013
Estimated recovery: 3Q 2013

Please check with your wholesaler for available inventory.

Shortage per Manufacturer: Manufacturing delay

Other

Reverified 6/14/2013

Amytal Sodium Injection (Initial posting date - 1/31/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Marathon Pharmaceuticals, LLC Customer Service: 1 866- 945-7860	Amytal Sodium Amobarbital Sodium for Injection, USP 0.5g; 10mL vial (NDC 42998-303-01)	Available	Please check with your wholesaler for available inventory	Manufacturing	Revised 5/7/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Marathon Pharmaceuticals, LLC
Customer Service:
1 866- 945-7860

Amytal Sodium
Amobarbital Sodium for Injection, USP
0.5g; 10mL vial

(NDC 42998-303-01)

Available

Please check with your wholesaler for available inventory

Manufacturing

Revised 5/7/2013

Atracurium Besylate (updated 2/27/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Bedford Customer Service: 1-800-562-4797	10 mg/mL, 5 mL vial, single dose vial (NDC 55390-0102-05)		Bedford Laboratories has 50mg Inj SDV 5ml and 100mg Inj MDV 10ml available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: Manufacturing delays	Discontinuation of the manufacture of the drug.	Revised 4/10/2012
	10 mL vial, multi-dose vial (NDC 55390-0103-10)
	5 mL Novaplus vial, single dose vial (NDC 55390-0180-05)
	10 mL Novaplus vial, multi-dose vial (NDC 55390-0179-10)
Hospira, Inc. Customer Service: 1-877-946-7747	10 mg/mL; 5 mL vial (NDC 0409-1109-01)	Available	New product launch.	Other	Reverified 6/14/2013
Hospira, Inc. Customer Service: 1-877-946-7747	10 mg/mL; 10 mL vial (NDC 0409-1105-02)	Available	New product launch.	Other	Reverified 6/14/2013
Sagent Pharmaceticals 1-866-625-1618	10 mg/mL, 5 mL single dose vial, (NDC 25021-659-05)	Available	Products launched end of May, 2012.	Demand increase for the drug.	Reverified 6/3/2013
	10 mg/mL, 10 mL multi-dose vial (NDC 25021-672-10)	Available

Atropine Sulfate Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136	0.1 mg/mL, 10 mL, Luer-Jet Prefilled Syringe NDC 76329-3339-1 (old NDC 00548-3339-00)	Amphastar will regularly release products.	Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues.	Demand increase for the drug	Reverified 5/28/2013
Hospira, Inc. Customer Service: 1-877-946-7747	0.1 mg/mL; 10 mL Ansyr syringe (NDC 0409-1630-10)	Next delivery and estimated recovery TBD	Please check with your wholesaler for available inventory. Shortage per Manufacturer: Manufacturing delay; Material shortage	Other	Revised 6/14/2013
	0.05 mg/mL; 5 mL Ansyr syringe (NDC 0409-9630-05)	Next delivery and estimated recovery TBD
	0.1 mg/mL; 5 mL Lifeshield syringe (NDC 0409-4910-34)	Next delivery early July Estimated recovery 3Q 2013
	0.1 mg/mL; 10 mL Lifeshield syringe (NDC 0409-4911-34)	Next delivery mid June Estimated recovery 3Q 2013
	0.1 mg/mL; 10 mL Lifeshield syringe (NDC 0409-4911-34)	Next delivery mid June Estimated recovery 3Q 2013
American Regent/Luitpold 1-800-645-1706	0.4 mg/mL, 0.5 mL ampule, package of 25 (NDC 00517-0805-25)	Unavailable	American Regent/Luitpold has discontinued manufacturing the ampoules	Discontinuation of the manufacture of the drug. Other	Reverified 6/18/2013
	0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25)	Unavailable	American Regent is currently not releasing Atropine Sulfate Injection 0.4 mg/mL, 1 mL single-dose vial
	1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25)	Unavailable
	1 mg/mL, 1 mL ampule, package of 25 (NDC 00517-0101-25)	Available	American Regent is currently releasing Atropine Sulfate Injection 1 mg/mL, 1 mL single-dose vial
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	0.4 mg/mL, 20 mL vial (NDC 0641-6006-10)	West-Ward currently experiencing a backorder sitation.	West-Ward has accelerated production to meet increased demand. Several lots are scheduled for production and anticipated to be available by the end of February 2013. Product will be made available as it is released.	Demand increase for the drug.	Revised 2/11/2013

Bacteriostatic 0.9% Sodium Chloride (Initial posting-9/10/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	20 mL vial (NDC 0409-1966-05)	Available	Please check with your wholesaler for available inventory. Shortage per Manufacturer: manufacturing delay	Other	Reverified 6/14/2013
	30 mL vial (NDC 0409-1966-07)	Available
	10 mL vial (NDC 0409-1966-12)	Available
	10 mL vial (NDC 0409-1966-12)	Available
APP 1-888-386-1300	30 mL MD Vial Glass (NDC # 63323-259-30)	Available. Check wholesalers for inventory.	Shortage per Manufacturer: Increased demand	Demand increase for the drug	Reverified 6/5/2013
	30 mL MD Vial Plastic (NDC # 63323-924-30)	Available. Check wholesalers for inventory.
	10mL MD Vial Plastic (NDC # 63323-924-10)	Available Check wholesalers inventory.
	10mL MD Vial Plastic (NDC # 63323-924-10)	Available Check wholesalers inventory.

Barium Sulfate for Suspension (Initial posting-10/12/2012)

Company	Product	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Bracco Diagnostics Customer Service: 1-800-631-5245	E-Z-HD BARIUM SULFATE FOR SUSPENSION (98% w/w),(NDC 32909-764-01)	Shortage of an active ingredient.	Reverified 1/11/2013



	DIGIBAR 190 BARIUM SULFATE FOR SUSPENSION, (190% w/v when constituted 232 g), (NDC 32909-270-19 )	Demand increase for the drug
		Demand increase for the drug
	MAXIBAR BARIUM SULFATE SUSPENSION (210% w/v, 80% w/w),(NDC 32909-150-08)	Demand increase for the drug
	LIQUID E-Z-PAQUE BARIUM SULFATE SUSPENSION (60% w/v, 41% w/w),(NDC 32909-186-02)	Shortage of an active ingredient.
	LIQUID E-Z-PAQUE BARIUM SULFATE SUSPENSION (60% w/v, 41% w/w),(NDC 32909-186-01)	Shortage of an active ingredient.
	LIQUID POLIBAR PLUS BARIUM SULFATE SUSPENSION (105% w/v, 58% w/w), (NDC 32909-168-02)	Demand increase for the drug
	POLIBAR ACB BARIUM SULFATE (96% w/w), (NDC 32909-804-01)	Shortage of an active ingredient.
	POLIBAR ACB BARIUM SULFATE (96% w/w), NDC 32909-804-02	Shortage of an active ingredient.
	E-Z-CAT DRY BARIUM SULFATE FOR SUSPENSION (2% w/w After Mixing), (NDC 32909-727-01)	Shortage of an active ingredient.
	E-Z-DISK BARIUM SULFATE TABLETS (NDC 10361-778-31)	Demand increase for the drug

Bismuth Subsalicylate; Metronidazole; Tetracycline Hydrochloride (Helidac) (Initial Posting - 3/8/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Prometheus Laboratories Inc. 1-888-423-5227 option 3	HELIDAC (bismuth subsalicylate/tetracycline hydrochloride/metronidazole) Therapy (NDC 65483-495-14)	Prometheus has limited product available and cannot estimate a release date for new batches.	Shortage per Manufacturer: Material Shortage (Tetracycline HCl capsules)	Shortage of an active ingredient.	4/4/2012

Bumetanide Injection (Initial posting-6/21/12)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	0.25mg/mL; 4mL (NDC 00409-1412-04)	Next delivery July Estimated recovery: 3Q 2013	Drug product allocated to direct orders Shortage per manufacturer: Manufacturing delay.	Other	Revised 6/14/2013
Hospira Inc. Customer Service: 1-877-946-7747	0.25mg/mL; 10mL vial (NDC 00074-1412-10)	Next delivery early July Estimated recovery: 3Q 2013		Other	Revised 6/14/2013
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	Bumetanide Injection, USP 0.25 mg/mL, 10 mL vial (NDC 0641-6007-10)	West-Ward is currently experiencing a backorder situation on the 4 mL vial. Quantities of the 10 mL vial are available. West-Ward has accelerated production on this product	West-Ward is anticipating having product available by the middle of February 2013. Product will be made available as it is released.	Demand increase for the drug.	Revised 2/11/2013
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	0.25mg/mL, 4mL vial (NDC 00641-6008-10)			Demand increase for the drug.	Revised 2/11/2013
Bedford Customer Service: 1-800-562-4797	0.25mg/mL, 2 mL vial (NDC 55390-0500-02)	Not available	Shortage per Manufacturer: Manufacturing delay	Discontinuation of the manufacture of the drug.
	0.25mg/mL, 4 mL vial (NDC 55390-0500-05)
	0.25mg/mL, 10 mL vial (NDC 55390-0500-10)

Bupivacaine Hydrochloride (Marcaine, Sensorcaine) Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP 1-888-386-1300		APP has Sensorcaine (with & without Epinephrine) on intermittent back-order and the company is releasing product as it becomes available. Check Wholesaler Inventory.	Shortage per Manufacturer: Increased demand	Demand increase for the drug.	Reverified 6/5/2013
Hospira, Inc. Customer Service 1-877-946-7747	0.25%; 30 mL amp (NDC 0409-1158-01)	Available	Please check with your wholesaler for available inventory. NDC 0409-7600-01: Production temporarily suspended due to other production priorities. Shortage per Manufacturer: manufacturing delay/Available	Other	Revised 6/14/2013
	0.25%; 10 mL vial (NDC 0409-1159-01)	Next delivery early June Estimated recovery 3Q 2013
	0.25%; 30 mL vial (NDC 0409-1159-02)	Available
	0.25%; 50 mL vial (NDC 0409-1160-01)	Next delivery June Estimated recovery 3Q 2013
	0.5%; 30 mL amp (NDC 0409-1161-01)	Available
	0.5%; 10 mL vial (NDC 0409-1162-02)	Next delivery early June Estimated recovery 3Q 2013
	0.5%; 10 mL vial (NDC 0409-1162-01)	Next delivery July Estimated recovery 4Q 2013

	0.5%; 50 mL vial (NDC 0409-1163-01)	Next delivery late July Estimated recovery 3Q 2013
	0.75%; 10 mL vial (NDC 0409-1165-01)	Next delivery late July Estimated recovery 3Q 2013
	0.75%; 30 mL vial (NDC 0409-1165-02)	Next delivery early June Estimated recovery June
	0.75% in Dex 8.25%; 2mL amp (NDC 0409--3613-01)	Available
	0.5% w/epi 1:200,000; Carpules (NDC 0409-7600-01)	Next delivery TBD
	0.25% w/epi 1:200,000; 10 mL vial (NDC 0409-9042-01)	Available
	0.25% w/epi 1:200,000; 30 mL vial(NDC 0409-9042-17)	Next delivery June Estimated recovery: 3Q 2013


	0.25% w/epi 1:200,000; 50 mL (NDC 0409-9043-01)	Next delivery July Estimated recovery: 3Q 2013
	0.25% w/epi 1:200,000; 50 mL (NDC 0409-9043-01)	Next delivery July Estimated recovery: 3Q 2013
	0.5% w/epi 1:200,000; 10 mL (NDC 0409-9045-01)	Available
	0.5% w/epi 1:200,000; 30 mL (NDC 0409-9045-17)	Next delivery July Estimated recover 3Q 2013
	0.5% w/epi 1:200,000; 50 mL (NDC 0409-9046-01)	Next delivery July Estimated recovery: 3Q 2013
	50 mg/20 mL Sterile pack amp (NDC 0409-4272-01)	Available
	100mg/20mL Sterile pack amp (NDC 0409-4273-01)	Available

Buprenorphine Hydrochloride (Buprenex) Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Bedford 1-800-562-4797	1 mL vial (NDC 55390-0010-10)		Bedford has buprenorphine injection on back order and the company cannot estimate a release date. Shortage per Manufacturer: Delays	Discontinuation of the manufacture of the drug.
Hospira 1-877-946-7747	1 mL Carpuject syringe (NDC 0409-2012-32	Next delivery and estimated recover TBD		Shortage of an active ingredient/Demand increase for the drug.	Reverified 6/14/2013
American Regent/Luitpold 1-800-645-1706	0.3 mg (base/mL) 1 mL vial (NDC 00517-0725-05)	Unavailable	Shortage per Manufacturer: American Regent is currently not releasing Buprenorphine Injection	Other	Reverified 6/18/2013
Reckitt Benckiser 804-379-1090 Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01)	Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) are available		Reckitt Benckiser has Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) available.	Other

Caffeine, anhydrous (125 mg/mL) and Sodium benzoate (125 mg/mL)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
American Regent/Luitpold: 631-924-4000	2 mL single-dose vial, package of 10 (NDC 00517-2502-10)	Unavailable	American Regent is currently not releasing Caffeine and Sodium Benzoate Injection	Other	Reverified 6/18/2013

Caffeine and Ergotamine Tartrate Tablet (Cafergot) (Initial Posting-3/8/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Sandoz Customer Service: 1-609-627-8500	100 mg caffeine/ 1 mg ergotamine tartrate; 100 count bottle (NDC 00781-5405-01	Temporarily unavailable and Sandoz cannot estimate a release date.	Change in the raw material plant location, we will continue to provide updates as further information becomes available.	Shortage of an active ingredient.	Reverified 4/16/2013

Calcium Chloride Injection (Initial Posting 12/13/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	100 mg/mL; 10 mL Abboject (NDC 0409-4928-34)	Next delivery early July Estimated recovery 4Q 2013	Please check with your wholesaler for available inventory. Shortage per manufacturer: Manufacturing delay	Other	Revised 6/14/2013
Hospira Inc. Customer Service: 1-877-946-7747	100 mg/mL; 10 mL Ansyr (NDC 0409-1631-10)	Next delivery late June Estimated recovery 3Q 2013		Other	Revised 6/14/2013
American Regent/Luitpold 1-800-645-1706	10 mL single-dose vial, package of 25 (NDC 00517-2710-25)	Temporarily unavailable. Next delivery end of June.		Other	Revised 6/18/2013
American Regent/Luitpold 1-800-645-1706	10 mL single-dose vial, package of 25 (NDC 00517-2710-25)	Temporarily unavailable. Next delivery end of June.		Other	Revised 6/18/2013
Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136	10%, 10mL Luer-Jet Prefilled Syringe NDC 76329-3304-1 (old NDC 0548-3304-00)	Amphastar will regularly release products.	Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues	Demand increase for drug	Reverified 5/28/2013
		Amphastar will regularly release products.		Demand increase for drug	Reverified 5/28/2013

Calcium Gluconate Injection (Initial Posting 1/10/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
American Regent/Luitpold: 1-800-645-1706 1-877-946-7747	10% 50 mL vial Calcium (0.465 mEq/mL), Preservative Free (NDC 0517-3950-25)	Temporarily unavailable	American Regent is currently releasing Calcium Gluconate 100mL Pharmacy Bulk Package	Other	Reverified 6/18/2013
American Regent/Luitpold: 1-800-645-1706 1-877-946-7747	10% 100 mL vial Calcium (0.465 mEq/mL), Preservative Free (NDC 0517-3900-25)			Other	Reverified 6/18/2013
APP 1-888-386-1300	10% 10 mL vial Calcium (0.465 mEq/mL), Preservative Free 1 g/ 10 mL, SDV (NDC 63323-311-10)	Manufacturer is currently allocating.		Demand increase for the drug.	Revised 6/5/2013
	10% 50 mL vial Calcium (0.465 mEq/mL), Preservative Free 5 g/ 50 mL, SDV (NDC 63323-311-50)	Backordered. Next delivery anticipated late June 2013.
		Back-ordered. Next delivery anticipated June 2013.
	10% 100 mL vial Calcium (0.465 mEq/mL), Preservative Free 10 g/ 100 mL, PBP (NDC 63323-311-61)	Back-ordered. Next delivery anticipated June 2013.

Chromic Chloride Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira, Inc. Customer Service 1-877-946-7747	4 mcg/mL; 10 mL vial (NDC 0409-4093-01)	Next delivery mid-June Estimated recovery June	Shortage per Manufacturer: Other manufacturer shortage.	Other	Revised 6/14/2013
American Regent/Luitpold 1-800-645-1706	4 mcg/mL; 10 mL vial, 25s (NDC 00517-6310-25)	Unavailable	American Regent is currently not releasing Chromic Chloride Injection	Other	Revised 6/18/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Hospira, Inc.
Customer Service
1-877-946-7747

4 mcg/mL; 10 mL vial
(NDC 0409-4093-01)

Next delivery mid-June

Estimated recovery June

Shortage per Manufacturer:

Other manufacturer shortage.

Other

Revised 6/14/2013

American Regent/Luitpold
1-800-645-1706

4 mcg/mL; 10 mL vial, 25s (NDC 00517-6310-25)

Unavailable

American Regent is currently not releasing Chromic Chloride Injection

Other

Revised 6/18/2013

Cidofovir Injection (Initial posting– 2/15/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Heritage Pharmaceuticals, Inc. 1-866-901-1230	375 mg/5 mL vial (NDC 2315-5216-31)	Available	Gilead Sciences, Inc. issued a recall for Vistide (cidofovir injection) on February 7, 2013 (NDC 61958-0101-1; Lot # B120217A). Information concerning this recall can be found at: http://www.gilead.com/pdf/Vistide-Recall-Pharmalert.pdf Heritage Pharmaceuticals and Mylan Institutional have product available.		Reverified 4/10/2013
Mylan Institutional 1-888-258-4199	375 mg/5 mL vial (NDC 67457-210-05	Available			Reverified 6/5/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Heritage Pharmaceuticals, Inc.

1-866-901-1230

375 mg/5 mL vial (NDC 2315-5216-31)

Available

Gilead Sciences, Inc. issued a recall for Vistide (cidofovir injection) on February 7, 2013 (NDC 61958-0101-1; Lot # B120217A). Information concerning this recall can be found at: http://www.gilead.com/pdf/Vistide-Recall-Pharmalert.pdf

Heritage Pharmaceuticals and Mylan Institutional have product available.

Reverified 4/10/2013

Mylan Institutional

1-888-258-4199

375 mg/5 mL vial

(NDC 67457-210-05

Available

Reverified 6/5/2013

Citric Acid; Gluconolactone; Magnesium Carbonate Solution (Renacidin); Irrigation (Initial posting– 6/30/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
United Guardian Customer Service: 1-800-645-5566	Renacidin® Irrigation 6.602GM/100ML;198MG/100ML;3.177GM/100ML (NDC: 00327-00011-05)	Availability is not expected before May 2013	Shortage per Manufacturer: Manufacturing Delay	Other	Revised 10/29/2012

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

United Guardian

Customer Service:
1-800-645-5566

Renacidin® Irrigation

6.602GM/100ML;198MG/100ML;3.177GM/100ML

(NDC: 00327-00011-05)

Availability is not expected before May 2013

Shortage per Manufacturer:
Manufacturing Delay

Other

Revised 10/29/2012

Copper Injection (Cupric Chloride) (Initial posting– 4/25/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
American Regent/Luitpold 1-800-645-1706	Cupric Sulfate Injection 0.4 mg/mL 10 mL vial, package of 25 (NDC 00517-6210-25	Cannot provide an estimated date of availability	American Regent is currently not releasing Cupric Sulfate Injection	Other	Reverified 6/18/2013
Hospira Inc. Customer Service: 1-877-946-7747	0.4 mg/mL; 10 mL vial (NDC 0409-4092-01)	Next delivery mid July Estimated recovery: 3Q 2013	Please check with your wholesaler for available inventory. Shortage per Manufacturer: Manufacturing Delay	Other	Revised 6/14/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

American Regent/Luitpold

1-800-645-1706

Cupric Sulfate Injection 0.4 mg/mL

10 mL vial, package of 25 (NDC 00517-6210-25

Cannot provide an estimated date of availability

American Regent is currently not releasing Cupric Sulfate Injection

Other

Reverified 6/18/2013

Hospira Inc. Customer Service:
1-877-946-7747

0.4 mg/mL; 10 mL vial
(NDC 0409-4092-01)

Next delivery mid July
Estimated recovery: 3Q 2013

Please check with your wholesaler for available inventory.
Shortage per Manufacturer: Manufacturing Delay

Other

Revised 6/14/2013

Cyanocobalamin Injection (Initial posting– 1/25/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
American Regent/Luitpold 1-800-645-1706	1000 mcg/mL, 1 mL vial (NDC 00517-0031-25)	Available	American Regent is currently releasing the 1 mL, 10 mL and 30 mL vials.		Reverified 6/18/2013
	1000 mcg/mL, 10 mL vial (NDC 00517-0032-25)	Available
	1000 mcg/mL, 30 mL vial (NDC 00517-0130-05)	Available
APP 1-888-386-1300	1000 mcg/mL, 1 mL vial (NDC 63323-0044-01)	Currently back-ordered - next release anticipated late June 2013. Check wholesalers for inventory.	Check wholesalers for inventory	Increased Demand	Revised 6/5/2013

Daunorubicin Hydrochloride Solution for Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Teva Pharmaceuticals 1-800-545-8800	5 mg/mL, 4 mL single-dose vial (NDC 00703-5233-13)	Teva has ample supply available		N/A	Reverified 5/29/2013
Bedford Customer Service 1-800-562-4797	5 mg/mL, 4 mL single-dose vial (NDC 55390-0108-10)	Available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown.	Availability of products is updated on the Bedford Laboratories website Shortage per Manufacturer: Manufacturing delays	Discontinuation of the manufacture of the drug.	Revised 4/10/2012
	10 mL single-dose vial (NDC 55390-0108-01)
	Cerubidine lyophilized powder for injection, 20mg single-dose vial, package of 10 (NDC 55390-0281-10)

Denileukin diftitox (Ontak) Initial posting - (9/22/2011)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Eisai 1-888-422-4743	150 mcg/mL, Eisai 2 mL vial (NDC 62856-0603-01)	Eisai is working to have product available again.	For information on Patient Access Program, please visit: http://www.ontak.com/ Shortage per Manufacturer: Manufacturing issue	Other	Reverified 1/24/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Eisai
1-888-422-4743

150 mcg/mL, Eisai
2 mL vial (NDC 62856-0603-01)

Eisai is working to have product available again.

For information on Patient Access Program, please visit: http://www.ontak.com/

Shortage per Manufacturer:
Manufacturing issue

Other

Reverified 1/24/2013

Desmopressin Acetate (DDAVP) Injection Initial posting - (5/7/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Sanofi-Aventis 1-800-981-2491	4 mcg/mL, 1mL ampule (NDC 0075-2451-01)	Product is currently available	No supply issue anticipated	N/A
Sanofi-Aventis 1-800-981-2491	4 mcg/mL, 10 mL vial (NDC 0075-2451-53)	Product is currently available	No supply issue anticipated	N/A
Hospira Inc. Customer Service: 1-877-946-7747	4 mcg/mL; 1 mL ampules (NDC 0409-2265-01)	Next delivery 2014 Estimated recovery: 2014	Shortage per Manufacturer: Manufacturing delay.	Other	Reverified 6/14/2013
Hospira Inc. Customer Service: 1-877-946-7747	4 mcg/mL; 1 mL ampules (NDC 0409-2265-01)	Next delivery 2014 Estimated recovery: 2014	Shortage per Manufacturer: Manufacturing delay.	Other	Reverified 6/14/2013
Teva Pharmaceuticals 1-800-545-8800	4MCG/ML 10X1ML (NDC00703-5051-03)	Next delivery 2016		Method remediation and transfer
Teva Pharmaceuticals 1-800-545-8800	4MCG/ML 1X10ML (NDC00703-5054-01)	Next delivery 2016		Method remediation and transfer

Dexamethasone Sodium Phosphate Injection (Initial posting– 1/15/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
American Regent/Luitpold 1-800-645-1706	4 mg/mL, 1 mL single dose vial (NDC 00517-4901-25)	Unavailable	American Regent is currently not manufacturing Dexamethasone Sodium Phosphate Injection, USP.	Other	Reverified 6/18/2013


	4 mg/mL, 5 mL multiple dose vial (NDC 00517-4905-25)
	4 mg/mL, 5 mL multiple dose vial (NDC 00517-4905-25)
	4 mg/mL, 30 mL multiple dose vial (NDC 00517-4930-25)



APP Customer Service 1-888-386-1300	4 mg/mL, 1 mL single dose vial (NDC 63323-0165-01)	Available. Check wholesaler inventory	Check wholesalers for inventory on all presentations.	Increase in demand	Revised 6/5/2013
	4 mg/mL, 1 mL single dose vial (NDC 63323-0165-01)	Available. Check wholesaler inventory
	20 mg/5 mL single dose vial (NDC 63323-0165-05)	Available. Check wholesaler inventory
	120 mg/30 mL multiple dose vial (NDC 63323-0165-30)	Available. Check wholesaler inventory
	10 mg/mL, single dose vial (NDC 63323-0506-01)	10 mg/ml single dose vial back-ordered. Next release anticipated June 2013.
	10 mg/mL, single dose vial (NDC 63323-0506-01)	100 mg/10 mL multiple-dose vial Backordered. Next release expected July 2013
	100 mg/10 mL multiple-dose vial (NDC 63323-0516-10)


Pfizer Injectables 1 800-533-4535	Dexamethasone 100mg/10mL (10mg/mL) pkg of 10 (NDC 0069-4541-02)	Limited supply. Estimated recovery 9/30/2013		Delay in shipping drug.	Revised 6/6/2013
	Dexamethasone 120mg/30mL (4mg/mL) Pkg of 25 (NDC 0069-4545-02)	Limited supply. Estimated recovery 6/24/2013
	Dexamethasone 20mg/5mL (4mg/mL) Pkg of 25 (NDC 0069-4543-02)	Available
	Dexamethasone 4mg/mL Pkg of 25 (NDC 0069-4547-02)	Available
		Lots shipping weekly with full recovery by 8/26/2013


West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	Dexamethasone Sodium Phosphate Injection, USP 1 mL vial, 10 mg/mL (NDC 0641-0367-25)	West-Ward currently has limited quantities available. West-Ward has continued to accelerate production on this product.	Additional lots are scheduled for manufacturing with anticipated availability by end of March 2013. Product will be made available as it is released.	Increase in product demand due to market supply issues.	Revised 2/11/2013

Dexrazoxane Injection (Zinecard)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Mylan Institutional 1-888-258-4199	250 mg vial (NDC 67457-0207-25)	Available		Demand increase for the drug.	Reverified 6/5/2013
Mylan Institutional 1-888-258-4199	500 mg vial (NDC 67457-208-50)	Available		Demand increase for the drug.	Reverified 6/5/2013
Pfizer Injectables 1-800-533-4535 http://www.pfizerinjectables.com/	250mg vial (NDC 0013-8717-62)	Pfizer has product available for both strengths.	Pfizer Injectables has available vials of 250 mg NDC (0013-8717-62), 500 mg (NDC 0013-8727-89).	Other	Reverified 6/6/2013
	500mg (NDC 0013-8727-89)	Pfizer has product available for both strengths.		Other	Reverified 6/6/2013
Topotarget USA, Inc. 1-973-895-6900	Totect 500 mg (dexrazoxane) for injection (NDC 38423-110-01)		Topotarget USA has worked with the US Food and Drug Administration (FDA) to increase the availability of Totect Kits. Effective February 6, 2012, the FDA has approved the extension of the expiration date to 36 months for Totect Kits with following batch numbers: Batch 1914008/W005755/008 expired Nov 2011 (Dear Healthcare Customer Letter 008 PDF - 78KB) Batch 1925943/W005755/009 expired Dec 2011 (Dear Healthcare Customer Letter 009 PDF - 75KB) Batch 1979183/W005755/010 expired Mar 2012 (Dear Healthcare Customer Letter 010 PDF - 75KB) Batch 1985218/W005755/011 expired Mar 2012 (Dear Healthcare Customer Letter 011 PDF - 75KB) Topotarget USA, Inc. has recently released additional 129 kits to help fill the back order for this product. The company cannot estimate a release for additional Totect Kits at this time. Shortage per Manufacturer: Manufacturing Delays	Other	Revised 4/26/2012

Dextrose Injection (Initial posting – 5/23/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136	50%, 50mL Luer-Jet Prefilled Syringe NDC 76329-3301-1 (old NDC 0548-3301-00)	Amphastar will regularly release products	Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. Shortage per Manufacturer: Increased Demand	Demand increase for the drug.	Reverified 5/28/2013
Hospira, Inc. Customer Service 1-877-946-7747	50%; 50mL vial (NDC 00409-6648-02)	Next delivery early July Estimated recovery 3Q 2013	Shortage per Manufacturer: Manufacturing delay	Other: Demand increse for the drug	Revised 6/14/2013
	50%; 50mL Abboject Syringe (NDC 00409-4902-34)	Next delivery mid June Estimated recovery 3Q 2013
	50%; 50mL Ansyr Syringe (NDC 00409-7517-16)	Next delivery early July Estimated recovery 3Q 2013
	50% in Water; 500 mL in 1000 mL (NDC 00409-7936-19)	Next delivery August Estimated recovery August
	25%; 10mL Ansyr Syringe (NDC 0409-1775-10)	Next delivery mid-July Estimated recovery 3Q 2013

Diazepam Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira, Inc. Customer Service: 1-877-946-7747	5 mg/mL; 2 mL Carpuject (0409-1273-32)	Available	Shortage per Manufacturer: manufacturing delay	Other	Revised 6/14/2013
Hospira, Inc. Customer Service: 1-877-946-7747	5 mg/mL; 10 mL vial (0409-3213-12)	Next delivery mid June Estimated recovery: June	Shortage per Manufacturer: manufacturing delay	Other	Revised 6/14/2013

Dipyridamole Injection (Initial posting-7/24/12)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	Dipyridamole Injection, USP (Formerly a Baxter Product) 5 mg/mL; 10 mL vial (NDC 0641-2569-44)	West-Ward is currently experiencing a backorder situation. West-Ward has increased production and is anticipating having product available by the end of January 2013. Additional lots are projected to be available in February 2013. Product will be made available as it is released.	Shortage per Manufacturer: Increase in product demand due to market supply issues. West-Ward has accelerated production on this product.	Demand increase for the drug.	Revised 1/7/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

West-Ward Pharmaceuticals

Customer Service:
1-800-631-2174

Dipyridamole Injection, USP
(Formerly a Baxter Product)

5 mg/mL; 10 mL vial
(NDC 0641-2569-44)

West-Ward is currently experiencing a backorder situation.

West-Ward has increased production and is anticipating having product available by the end of January 2013.

Additional lots are projected to be available in February 2013.

Product will be made available as it is released.

Shortage per Manufacturer:
Increase in product demand due to market supply issues.

West-Ward has accelerated production on this product.

Demand increase for the drug.

Revised 1/7/2013

Dobutamine Hydrochloride Injection (Initial posting-4/26/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Baxter Healthcare Customer Service: 1-888-229-0001	Dobutamine Hydrochloride in 5% Dextrose Injection 250 mg/250 mL (NDC 00338107302)	Baxter continues to release product and anticipates supplies to recovery by June/July 2013.		Demand increase for the drug.	Reverified 5/7/2013
	Dobutamine Hydrochloride in 5% Dextrose Injection 500 mg/ 250 mL (NDC 00338107502)
	Dobutamine Hydrochloride in 5% Dextrose Injection 1000 mg/250 mL (NDC 00338107702)
Hospira Inc. Customer Service: 1-877-946-7747	12.5 mg base/mL; 20 mL vial (NDC 0409-2025-20)	Next delivery September. Estimated recovery 3Q 2013.	Shortage per Manufacturer: Manufacturing delay.	Other	Revised 6/14/2013
	12.5 mg base/mL; 40 mL vial (NDC 0409-2025-54)	Next delivery July. Estimated recovery 3Q 2013.
	12.5 mg base/mL; 20 mL vial (NDC 0409-2344-01)	Next delivery September. Estimated recovery 3Q 2013.
	12.5 mg base/mL; 40 mL vial (NDC 0409-2344-02)	Next delivery September. Estimated recovery 3Q 2013.
	1 mg/mL; 250 mL flexible container (in 5% dextrose) (NDC 0409-2346-32)	Next delivery early June. Estimated recovery early June.
	2 mg/mL; 250 mL flexible container (in 5% dextrose) (NDC 0409-2347-32)	Next delivery early June. Estimated recovery early June.
	4 mg/mL; 250 mL flexible container (in 5% dextrose) (NDC 0409-3724-32)	Next delivery early July. Estimated recovery early July.

Doxorubicin (adriamycin) lyophilized powder (updated 12/2/2011)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Bedford Laboratories Customer Service 1-800-562-4797	10 mg vials (NDC 55390-0231-01)	Bedford Laboratories has 10 mg available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Other presentations are pending release with release date yet to be determined.	Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: Manufacturing delays	Discontinuation of the manufacture of the drug.	Revised 4/10/2012
	20 mg vials (NDC 55390-0232-10)
	50 mg vials (NDC 55390-0233-01)
Pfizer Injectables 1-800-533-4535 http://www.pfizerinjectables.com/	10mg vials (NDC 0069-0170-01)	Avaialble		Other	Reverified 6/6/2013
	50mg vials (NDC 0069-0171-01)	Avaialble		Other	Reverified 6/6/2013

Doxycycline Hyclate (Initial Posting 1/18/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Mutual Customer Service: 1-800-523-3684	20 mg tablets, 100 count (NDC 53489-0647-01)	Available.	All presentations are available.		Reverified 5/20/2013
	50 mg capsules, 50 count (NDC 53489-0118-02)
	50 mg capsules, 500 count (NDC 53489-0118-05)
	100 mg tablets, 50 count (NDC 53489-0120-02)
	100 mg capsules, 50 count (NDC 53489-0119-02)
	100 mg tablets, 500 count (NDC 53489-0120-05)
	100 mg capsules, 500 count (NDC 53489-0119-05)
Mylan Customer Service: 1-800-796-9526	75 mg DR tablets, 60 count (NDC 0378-4531-91)	Available		Increased Demand	Reverified 5/20/2013
	100 mg DR tablets, 100 count (NDC 0378-4532-01)	Available
	100 mg DR tablets, 100 count (NDC 0378-4532-01)	Available
	150 mg DR tablets, 100 count (NDC 0378-3030-01)	Available
Watson Customer Service: 1-800-272-5525	50 mg capsules, 50 count (NDC 00591-5535-50)	Limited supplies available. Normal supply to be restored 09/2013	Watson is currently supporting supply for current contracted customers only.	Increased Demand	Revised 5/22/2013
	100 mg capsules, 50 count (NDC 00591-5440-50)
	100 mg capsules, 500 count (NDC 00591-5440-05)
	100 mg capsules, 500 count (NDC 00591-5440-05)
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	50 mg capsules, 50 count (NDC 00143-3141-50)	Available		Other	Reverified 5/22/2013
	50 mg capsules, 50 count (NDC 00143-3141-50)	Available
	100 mg tablets, 50 count (NDC 00143-2112-50)	Available
	100 mg capsules, 50 count (NDC 00143-3142-50)	Available
	100 mg capsules, 50 count (NDC 00143-3142-50)	Available
	100 mg capsules, 500 count (NDC 00143-3142-05)	Available
	100 mg capsules, 20 count (NDC 00143-3142-20)	Not currently packaging in this container size
	100 mg tablets, 500 count (NDC 00143-2112-05)	Available
	100 mg capsules, 50 count (NDC 0143-9803-50)	Available
	100 mg capsules, 500 count (NDC 0143-9803-05)	Available

Current Drug Shortages Index

Drugs

Section Contents Menu

Drug Safety and Availability

Resources for You

Current Drug Shortages A - D

Links on this page: